Steve Borzak, MD By Steve Borzak, MD, FACC The British Medical Journal published several papers this week detailing concerns about the bleeding risk of pradaxa (dabigatran), a coumadin substitute used for stroke risk reduction in atrial fibrillation. In the first article, investigative journalist Deborah Cohen…
Steve Borzak, MD By Steve Borzak, MD, FACC Liver Damage: Worry About Your Supplement, not Your Statin In a leading story on December 22, 2013, The New York Times featured new research showing an alarming rise in serious liver damage attributed to supplement use. In…
Steve Borzak, MD By Steve Borzak, MD, FACC This week saw the publication of yet another study showing that daily vitamins did nothing to reduce the risk of heart attack, stroke and vascular disease. This particular study, TACT, also tested chelation therapy and found a…
Steve Borzak, MD By Steve Borzak, MD, FACC After 9 years, the American Heart Association and American College of Cardiology published new guidelines for the evaluation and management of elevated cholesterol guidelines. Upon publication, they immediately generated controversy, such that the New York Times opined…
Fish oil is one of the most frequently used supplements. Recent data have questioned its efficacy, as well as raised concerns about its safety. Fish oil supplementation arose as an idea from population-based studies which found lower than expected rates of coronary heart disease in…
We are currently updating our website and online information. Please visit us soon to find the new information on the website. In the meantime please visit us on the Facebook and like us on our Florida Cardiology Facebook. We plan to update periodically here and on…